Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NBTY Reports High Rexall Brand Returns In Fourth Quarter

This article was originally published in The Tan Sheet

Executive Summary

The unusually high number of Rexall product returns during NBTY's fourth quarter may indicate product integration following the merger of the companies is not going as smoothly as anticipated

You may also be interested in...



Vitamin Market Weakness Paves Way For Acquisitions – NBTY

The impact of supplement industry stagnation and negative vitamin E publicity on smaller firms has created new acquisition opportunities for NBTY, President & CFO Harvey Kamil said

Vitamin Market Weakness Paves Way For Acquisitions – NBTY

The impact of supplement industry stagnation and negative vitamin E publicity on smaller firms has created new acquisition opportunities for NBTY, President & CFO Harvey Kamil said

Vitamin Market Weakness Paves Way For Acquisitions – NBTY

The impact of supplement industry stagnation and negative vitamin E publicity on smaller firms has created new acquisition opportunities for NBTY, President & CFO Harvey Kamil said

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS097649

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel